How much does Tymlos cost?
The list price for Tymlos (abaloparatide) is approximately $2,742 per month, which translates to about $32,904 annually for treatment [1]. This price is for the standard dosage, typically administered subcutaneously [1].
What factors influence the out-of-pocket cost of Tymlos?
The actual cost a patient pays for Tymlos can vary significantly based on insurance coverage, patient assistance programs, and whether they are using a discount card or coupon [1]. Many insurance plans have co-pays or deductibles that apply to prescription medications, and these can impact the final expense [1].
Are there patient assistance programs for Tymlos?
Yes, Radius Pharmaceuticals, the maker of Tymlos, offers a patient assistance program called the Tymlos Savings Card. This program can help eligible patients reduce their out-of-pocket costs for Tymlos, potentially lowering their monthly expenses to as little as $0 [1]. Eligibility for these programs is typically based on insurance status and income level [1].
How does Tymlos pricing compare to other osteoporosis treatments?
Tymlos is a biologic drug, and its pricing is generally in line with other injectable medications for osteoporosis, which can be expensive due to the complexity of their development and manufacturing [2]. For example, other injectable treatments for osteoporosis can also have monthly costs ranging from hundreds to thousands of dollars, depending on the specific drug and dosage [2].
When does the patent for Tymlos expire?
The patent landscape for Tymlos, like many branded pharmaceuticals, involves multiple patents covering various aspects of the drug, including its composition, method of use, and manufacturing processes [3]. Patent expiry dates can be complex due to patent extensions and potential litigation. Information regarding specific patent expiry dates for Tymlos is available through specialized patent databases [3]. DrugPatentWatch.com provides resources for tracking pharmaceutical patents and exclusivity periods [3].